Alembic Pharmaceuticals Limited (BOM:533573)

India flag India · Delayed Price · Currency is INR
936.25
-42.90 (-4.38%)
At close: Aug 26, 2025
-4.38%
Market Cap184.17B
Revenue (ttm)68.21B
Net Income (ttm)6.03B
Shares Outn/a
EPS (ttm)30.69
PE Ratio30.54
Forward PE24.48
Dividend11.00 (1.12%)
Ex-Dividend DateJul 29, 2025
Volume4,739
Average Volume5,497
Open991.95
Previous Close979.15
Day's Range930.00 - 991.95
52-Week Range725.60 - 1,296.15
Betan/a
RSI39.94
Earnings DateAug 4, 2025

About Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspe... [Read more]

Industry Pharmaceutical Preparations
Founded 1907
Employees 16,571
Stock Exchange Bombay Stock Exchange
Ticker Symbol 533573
Full Company Profile

Financial Performance

In 2024, Alembic Pharmaceuticals's revenue was 66.72 billion, an increase of 7.12% compared to the previous year's 62.29 billion. Earnings were 5.83 billion, a decrease of -5.26%.

Financial Statements

News

Alembic Pharma gains as USFDA approves Macitentan tablets for pulmonary arterial hypertension

Shares of Alembic Pharmaceuticals Ltd were in focus on Tuesday, August 19, after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Macite...

10 days ago - Business Upturn

Alembic Pharma shares jump over 2% as USFDA approves Tretinoin Cream USP

Shares of Alembic Pharmaceuticals gained over 2% on Monday, August 19, after the company announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbrevia...

11 days ago - Business Upturn

Top stocks to watch today, August 18: JK Cement, Swiggy, KEC International, Alembic Pharmaceuticals, Glenmark, auto stocks and more

Markets will track sector-specific developments and company announcements on Monday, August 18. Key updates span GST rationalisation measures, capex plans, earnings, and trade duty recommendations. Po...

11 days ago - Business Upturn

Stocks to watch today, August 18: Alembic Pharma, EMS, JK Cement, Star Cement, HDFC Bank, Vodafone Idea, Inox Wind and more

Indian markets are expected to see active stock-specific movements on Monday, August 18, as several companies announced fresh approvals, expansions, contract wins, earnings, and corporate actions. Her...

11 days ago - Business Upturn

Alembic Pharma share: Antique maintains buy, raises target to Rs 1,275 on US growth outlook

Antique Broking has maintained a ‘Buy’ rating on Alembic Pharmaceuticals, raising its target price to ₹1,275 from ₹1,154, citing strong growth momentum in the US business and stable domestic execution...

23 days ago - Business Upturn

Alembic Pharma gets USFDA nod for Carbamazepine Extended-Release Tablets

Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Carbamazepine Extended-Release Tablets US...

4 weeks ago - Business Upturn

Alembic Pharma acquires UK-based Utility Therapeutics for $12 million to expand US presence

Alembic Pharmaceuticals Inc., the wholly owned US subsidiary of Alembic Pharmaceuticals Limited, has announced the acquisition of UK-based Utility Therapeutics Ltd. This strategic move marks Alembic’s...

2 months ago - Business Upturn

Alembic Pharma share jump 3% after company gets US FDA approval for Doxorubicin Hydrochloride Injection

Shares of Alembic Pharmaceuticals rose nearly 3% in Monday morning trade after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its generic ...

2 months ago - Business Upturn

Alembic Pharma receives EIR from USFDA for Karakhadi API-III facility

Alembic Pharmaceuticals has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its API-III manufacturing facility located in Karakhadi, ...

2 months ago - Business Upturn

Pharma stocks in focus as Trump announces tariffs on sector ‘soon’

Indian pharmaceutical stocks are in focus today after U.S. President Donald Trump announced that pharma tariffs are coming very soon. According to industry data, companies with the highest U.S. revenu...

2 months ago - Business Upturn

Alembic Pharma shares dip over 2% after USFDA issues 4 observations for Panelav facility

Shares of Alembic Pharmaceuticals fell over 2% on Monday following news that the United States Food and Drug Administration (USFDA) issued four observations after inspecting the company’s API-I & II f...

3 months ago - Business Upturn

Alembic Pharmaceuticals shares in focus after USFDA nod for cancer drug Bosutinib

Shares of Alembic Pharmaceuticals may be in focus after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its generic Bosutinib Tablets in 10...

3 months ago - Business Upturn

Alembic Pharmaceuticals gets USFDA final approval for Amlodipine and Atorvastatin Tablets

Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amlodipine and Atorvastatin Tablets U...

3 months ago - Business Upturn

Alembic Pharma gets USFDA nod for Rivaroxaban tablets across four strengths; to launch 2.5 mg in Q1 FY26

Alembic Pharmaceuticals Limited announced on May 15 that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Rivaroxaban T...

3 months ago - Business Upturn

Alembic Pharma Q4 profit falls 12%, revenue rises 17%

Alembic Pharmaceuticals experienced a 12.1% dip in Q4 net profit, reaching Rs 156.63 crore, despite a 16.7% surge in revenue to Rs 1,769.64 crore. While India formulations and US revenue showed growth...

4 months ago - The Times of India

Alembic Pharmaceuticals shares drop 2% as Q4 net profit falls 11.9% YoY to Rs 156.89 crore

Alembic Pharmaceuticals saw a dip of over 2% in its shares following the announcement of Q4FY25 results. As of 2:08 PM, the shares were trading 1.94% down at Rs 887.85. Despite this, the company repor...

4 months ago - Business Upturn

Alembic Pharmaceuticals Q4 Results: Revenue rises 16.7% YoY to ₹1,769 crore, Net profit down 11.96% YoY

Alembic Pharmaceuticals Ltd announced its financial results for the fourth quarter of FY25, reporting a mixed set of numbers. The company posted a net profit of ₹157 crore, down 11.8% year-on-year (Yo...

4 months ago - Business Upturn

Alembic Pharma gets USFDA final nod for Ticagrelor 90 mg, tentative approval for 60 mg

Alembic Pharmaceuticals Limited announced on May 2, 2025, that it has received final approval from the US Food and Drug Administration (USFDA) for its Ticagrelor Tablets, 90 mg, and tentative approval...

4 months ago - Business Upturn

Alembic Pharma share price jumps 3% after USFDA issues EIR from for Panelav plant

Alembic Pharmaceuticals saw a 3% surge in its stock price after receiving a favorable Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA). The report follows an inspec...

4 months ago - Business Upturn

Stocks to watch today: Bajaj Finance, Infosys, Alembic Pharma, IndiaMART, Schaeffler India, CEAT in focus after key updates

Indian equities are expected to see stock-specific action on Wednesday as a host of companies reported quarterly results or announced corporate updates after market hours yesterday. Several firms acro...

4 months ago - Business Upturn

Alembic Pharmaceuticals gets USFDA final approval for Carbamazepine tablets USP 200 mg

Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Carbamazepine Tablets USP, 200 mg. These tablet...

4 months ago - Business Upturn

Alembic Pharmaceuticals gets USFDA final approval for Pantoprazole Sodium for Injection, 40 mg/vial

Alembic Pharmaceuticals Limited has announced the receipt of Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium for I...

5 months ago - Business Upturn

Pharma and hospital stocks in focus today: Alembic Pharma, Gland Pharma, Apollo Hospital, Fortis Healthcare, Dr Reddy’s [March 24, 2025]

Pharma and hospital-related stocks are seeing heightened investor interest today, March 24, 2025, following key developments. Alembic Pharma announced the successful completion of a US FDA inspection ...

5 months ago - Business Upturn

Top stocks to watch today, March 24: Alembic Pharma, Godrej Properties, NCC, Adani Green, Reliance Industries and more

Indian equity markets continued their stellar run, marking their best weekly performance in years. Investors shrugged off global uncertainties and snapped up undervalued stocks, pushing the benchmarks...

5 months ago - Business Upturn

Alembic Pharmaceuticals completes USFDA inspection at Karakhadi API-III facility with zero observations

Alembic Pharmaceuticals Limited has successfully concluded a scheduled inspection by the United States Food and Drug Administration (USFDA) at its API-III manufacturing facility located in Karakhadi, ...

5 months ago - Business Upturn